Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07294209 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients

Study acronym: DATE-AGING
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 49 to 51v7
  2. Study sites: 48 to 49v6
  3. Site details revised at 2 of 48 sitesv5
  4. Study sites: 46 to 48v4
  5. Study sites: 59 to 46v3
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 26, 2025 to Dec 19, 2025
    • Site details revised at 59 of 59 sites
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The DATE-AGING study is a prospective, multicenter, randomized controlled trial investigating low-dose tenecteplase in elderly patients with acute ischemic stroke. Its primary objective is to evaluate the safety and efficacy of low-dose tenecteplase in elderly patients within 4.5 hours of acute ischemic stroke onset.
Trial Details
NCT Number NCT07294209
Lead Sponsor Southwest Hospital, China
Conditions
(from sponsor)		 Acute Ischemic Stroke Patients
Enrollment 798 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov